UPLC-MS (Ultra Performance Liquid Chromatography-Mass Spectrometry)-based screening method of medicine for inhibiting activity of advanced glycosylation end product
Through UPLC-MS technology and comprehensive screening methods for in vitro, cell and animal experiments, the problem of difficult to quickly screen non-toxic and side-effect AGEs inhibitors in the existing technology is solved, and efficient screening and verification of AGEs is achieved, ensuring the drug safety and effectiveness.
Patent Information
- Application Number
- CN202310642355.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-01
- Publication Date
- 2024-12-03
AI Technical Summary
It is difficult to quickly and effectively screen out natural drugs that are non-toxic and have no side effects to inhibit advanced glycosylation end products (AGEs), which have an inhibitory effect on complications of diabetes.
Using UPLC-MS-based method, drugs with the ability to inhibit AGEs were screened through in vitro and cellular high-glycemic model experiments, and liquid quality detection was used by UPLC-MS, and the inhibitory effect of the drug was determined in combination with in vitro and cellular experiments, and verified through animal experiments. Differences in the effectiveness and dosage of drugs in the body.
It has achieved rapid screening of drugs with strong inhibitory effects of AGEs, which improves the accuracy and sensitivity of the analysis, simplifies the drug screening process, and ensures the safety and effectiveness of the drug.
Smart Images

Figure CN119064480A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of drug screening, and relates to a method for screening drugs for inhibiting the activity of advanced glycation end products based on UPLC-MS. Background Art
[0002] Advanced glycation end products (AGEs) are complex molecular entities produced by non-enzymatic glycosylation of proteins, involving the reaction between the carbonyl group of a reducing sugar and the free amino group of a protein. This reaction leads to the formation of a reversible Schiff base, which is then rearranged to form an Amadori product, which is further oxidized to form dicarbonyl compounds, forming cross-linked fluorescent (e.g., pentosidine) and non-fluorescent adducts (e.g., Nε-carboxymethyllysine), known as advanced glycation end products. These compounds often have complex structures and can provide a variety of biological functions on the surface of proteins. AGEs can be used to modulate the activity, stability, and affinity of proteins, which can have important effects on the function and biological activity of proteins in vivo.
[0003] Diabetes is a chronic metabolic disease characterized by hyperglycemia. Diabetic patients have an increased risk of various complications, including cardiovascular disease, retinopathy, kidney damage, nerve damage, etc. AGEs play an important role in diabetic complications. Studies have shown that persistent hyperglycemia in diabetic patients induces non-enzymatic glycosylation of multiple proteins in the body, leading to increased AGEs levels and further triggering a series of diabetic complications. The commonly used AGEs inhibitor is aminoguanidine. However, although aminoguanidine has a strong inhibitory effect on glycosylation, it also has serious side effects. Certain natural products, especially flavonoids rich in antioxidant properties, have been shown to have inhibitory effects on AGEs. Therefore, non-toxic and side-effect-free inhibitors based on natural plants are becoming a promising alternative. However, given the wide variety of existing drugs, it is particularly important to quickly screen out related drugs.
[0004] High performance liquid chromatography-mass spectrometry (HPLC-MS / MS) separates the glycosylated proteins in the sample in a high performance liquid chromatograph, and then sends the separated components to a mass spectrometer for analysis. Mass spectrometry (MS) is a technique for analyzing the composition and structure of chemical substances. It measures the mass and relative ion intensity of ions by ionizing the sample and separating the ions in an electric or magnetic field. By coupling with high performance liquid chromatography (HPLC), the high sensitivity and high resolution of mass spectrometry can be combined with the high efficiency and high selectivity of liquid chromatography to improve the accuracy and sensitivity of the analysis. Summary of the invention
[0005] The object of the present invention is to provide a UPLC-MS-based screening method for drugs that inhibit the activity of advanced glycation end products, so as to achieve rapid screening of drugs that inhibit AGEs.
[0006] The technical solution for achieving the purpose of the present invention is as follows:
[0007] The UPLC-MS-based method for screening drugs that inhibit the activity of advanced glycation end products comprises the following steps:
[0008] (1) Extraction of drugs:
[0009] The screened Chinese medicine was crushed into powder, and then boiled in 95% ethanol solution for 2 hours to extract the Chinese medicine components, and finally evaporated and concentrated at 60°C until it was in a paste state to obtain the Chinese medicine extract;
[0010] (2) Synthesis of AGEs in vitro:
[0011] A model group, a blank group, and a drug-treated group were set up, and the treatment of each group was as follows:
[0012] Model group: 5 mg / mL bovine serum albumin (BSA) and 0.5 mol / L D-ribose were mixed in PBS with pH 7.4, and allowed to stand at room temperature for one day to fully dissolve. The mixture was sterilized by filtration with a 0.22 μm sterile filter and then incubated at 5% CO 2 -95% O 2 Incubate at 37°C for 14 days;
[0013] Blank group: bovine serum albumin at a concentration of 5 mg / mL was sterilized by filtration with a 0.22 μm sterile filter and incubated at 5% CO 2 -95% O 2 Incubate at 37°C for 14 days;
[0014] Drug administration group: 5 mg / mL bovine serum albumin and 0.5 mol / L D-ribose were mixed in PBS with pH 7.4, left at room temperature for one day to fully dissolve, and sterilized by filtration with a 0.22 μm sterile filter. The Chinese herbal extract was dissolved in 10% dimethyl sulfoxide (DMSO), sterilized by filtration, and then added to the mixed reaction system of BSA and D-ribose at an addition amount of 2 mg / ml. The mixture was incubated at 5% CO 2 -95% O 2 Incubate at 37°C for 14 days;
[0015] (3) Liquid quality detection of AGEs:
[0016] After incubation, each group of samples was dialyzed with PBS to remove unreacted sugars, and then the samples were freeze-dried and dissolved in water, and sodium borohydride sodium borate buffer was added, incubated at room temperature for 2 hours, and then trifluoroacetic acid solution (TFA) was added, and the protein was precipitated by centrifugation at 12000g for 10 minutes. An equal amount of trifluoroacetic acid solution was added again and centrifuged, and the supernatant was removed. After all TFA was removed, HCl was added, and then the mixture was heated to 110°C under nitrogen blowing for 20 hours. The liquid was blown dry under nitrogen blowing, and the solid matter was dissolved in the LC-MS / MS starting eluent for liquid mass spectrometry testing. In the mobile phase, solvent A: 0.1% formic acid water (v / v,), solvent B: acetonitrile, flow rate 0.3mL / min, column temperature 40°C, gradient elution program as follows;
[0017]
[0018] Mass spectrometry conditions: ion source ESI (electrospray ionization) source, detection mode is positive ion detection, parameters are as follows:
[0019]
[0020] The content of synthesized AGEs in each group was analyzed;
[0021] (4) Establishment of cell high glucose model:
[0022] HBZY-1 (rat glomerular mesangial cells) cells were starved for 12 h in a culture medium without fetal bovine serum, and a model group, a blank group, and a drug-treated group were set up. The treatment of each group was as follows:
[0023] Blank group: HBZY-1 cells after starvation were cultured in DMEM low-glucose medium for 48 h;
[0024] Model group: HBZY-1 cells after starvation were cultured in DMEM high-glucose medium for 48 h;
[0025] Drug administration group: The Chinese herbal extract was dissolved in DMSO, filtered and sterilized with a sterile filter, added to DMEM high-glucose medium to a drug concentration of 100 g / ml, and then inoculated into starved HBZY-1 cells for 48 h.
[0026] (5) Detection of AGEs in cells by liquid chromatography-mass spectrometry
[0027] Methanol was added to each group, and the cells were mechanically separated from the plate with a scraper and transferred to a glass vial, completely dried, HCl was added to each sample, and the sample was incubated in a nitrogen blowing heating block at 110°C for 20 hours, and then dried under nitrogen blowing, and the bottom solid was dissolved in a mixed solution of acetonitrile and water containing 0.1% formic acid, with a volume ratio of water: acetonitrile of 1:1, and liquid chromatography-mass spectrometry was performed. The liquid chromatography-mass spectrometry conditions were the same as those in step (3), and the content of synthesized AGEs in each group was analyzed;
[0028] (6) Based on the contents of AGEs synthesized in steps (3) and (5), a comprehensive analysis is performed to screen out the drug with the relatively lowest content of synthesized AGEs.
[0029] Preferably, in step (3), in the sodium borohydride sodium borate buffer, the concentration of sodium borohydride is 100 mM, the concentration of the sodium borate buffer is 200 mM, and the pH is 9.2.
[0030] Preferably, in step (3), the concentration of the trifluoroacetic acid solution is 200 g / L.
[0031] Preferably, in step (3), data is collected in IDA (information-dependent basis) mode. In each data collection cycle, molecular ions with the highest signal intensity and a mass-to-charge ratio (m / z) greater than 100 are selected for secondary mass spectrometry collection. The bombardment energy used for ion fragmentation is 35±15 eV, and the accumulation time for each product ion is 50 ms.
[0032] Preferably, in step (4), the glucose concentration of the low-glucose medium is 5.6 mM, containing 5% heat-extinguished fetal bovine serum and 1% penicillin-streptomycin; the glucose concentration of the high-glucose medium is 30 mM, containing 5% heat-extinguished fetal bovine serum and 1% penicillin-streptomycin.
[0033] Compared with the prior art, the present invention has the following advantages:
[0034] (1) The method of the present invention first hydrolyzes and purifies the sample, and then uses different solvent systems in HPLC to separate the glycosylated proteins in the sample. The separated components are then analyzed by mass spectrometry to determine the glycosylation sites, and the type and amount of glycosylation. Compared with the traditional ELISA method, this method greatly improves the accuracy and sensitivity of the analysis, and can determine the glycosylation sites and types.
[0035] (2) The present invention first synthesizes AGEs in vitro to determine whether the selected drug has the ability to inhibit AGEs, uses a high-sugar model cell experiment to screen out the drug with the highest inhibitory ability, and uses a diabetes model animal experiment to determine the effectiveness and dosage differences of the screened drugs in vivo, thereby quickly screening the desired drugs. This method is simple and efficient. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 This is the liquid phase spectrum of AGEs in in vitro experiments;
[0037] Figure 2 To test the relative contents of various AGEs in vitro;
[0038] Figure 3 The ratio of various AGEs to total AGEs in in vitro experiments (A), the inhibition rate of different drugs on various AGEs (B1, B2) and the inhibition rate of different drugs on the overall level of AGEs;
[0039] Figure 4 This is the liquid phase spectrum of AGEs in cell experiments;
[0040] Figure 5 The relative contents of various AGEs for cell experiments;
[0041] Figure 6 The ratio of various AGEs to total AGEs in cell experiments (A), the inhibition rate of different drugs on various AGEs (B1, B2) and the inhibition rate of different drugs on the overall level of AGEs;
[0042] Figure 7 This is the liquid phase spectrum of AGEs in animal experiments;
[0043] Figure 8 The relative contents of various AGEs in animal experiments. DETAILED DESCRIPTION
[0044] The present invention is further described in detail below in conjunction with specific embodiments and drawings.
[0045] Example 1
[0046] In vitro experiments
[0047] Based on UPLC-MS, drugs that inhibit AGEs were quickly screened, and seven natural Chinese medicines, including white peony root, tangerine peel, rhubarb, cinnamon bark, scutellaria baicalensis, peony bark, and aurantium, were used as examples for detailed explanation.
[0048] 1. Extraction of drugs
[0049] Take 100g of each of the seven selected Chinese medicines, namely white peony root, dried orange peel, rhubarb, cinnamon bark, scutellaria baicalensis, peony bark and fructus aurantii, and grind them into powder using a wall-breaking machine. Then boil them in 95% ethanol solution for 2h to extract the Chinese medicine ingredients. Finally, evaporate and concentrate them in a rotary evaporator at 60℃ until they become a paste, and store them at 4℃ for later use.
[0050] 2. Synthesis of AGEs in vitro
[0051] Model group: 5 mg / mL bovine serum albumin (BSA) and 0.5 mol / L D-ribose were mixed in PBS (pH 7.4) and placed at room temperature for one day to fully dissolve. The mixture was sterilized by filtration with a 0.22 μm sterile filter and incubated at 5% CO 2 -95% O 2 Incubate at 37°C for 14 days.
[0052] Blank group: bovine serum albumin at a concentration of 5 mg / mL was used alone and sterilized by filtration with a 0.22 μm sterile filter. 2 -95% O 2 Incubate at 37°C for 14 days.
[0053] Drug administration group: 5 mg / mL bovine serum albumin (BSA) and 0.5 mol / L D-ribose were mixed in PBS (pH 7.4) and left at room temperature for one day to fully dissolve. Sterilize by filtration with a 0.22 μm sterile filter. The Chinese herbal extract was dissolved in 10% dimethyl sulfoxide (DMSO), filtered and sterilized, and then added to the mixed reaction system of BSA and D-ribose at an addition amount of 2 mg / ml. The mixture was incubated at 5% CO 2 -95% O 2 Incubate at 37°C for 14 days.
[0054] 3. Liquid-to-mass spectrometry to detect AGEs in vitro
[0055] After incubation, each group of samples was dialyzed extensively with PBS to remove unreacted sugars. The samples were then lyophilized, 20-40 mg of the solid was dissolved in water, and sodium borohydride (100 mM) dissolved in sodium borate buffer (200 mM, PH = 9.2) was added. Incubate at room temperature for 2 hours, then add trifluoroacetic acid (TFA, 200 g / L), and centrifuge at 12000g for 10 minutes to precipitate the protein. Add an equal amount of TFA again and centrifuge, and remove the supernatant. After removing all TFA, add HCl. Heat the mixture to 110°C with a nitrogen blower heating block and heat for 20 hours. Blow dry the liquid under nitrogen blowing, and dissolve the solid material in the LC-MS / MS starting eluent to start liquid-mass testing.
[0056] Phenomenex C18 chromatographic column (2.6m, 2.1×100mm), mobile phase: 0.1% formic acid water (v / v, solvent A) and acetonitrile (solvent B), gradient elution program see Table 1; flow rate 0.3mL / min; column temperature 40°C; injection volume 4μL.
[0057] Table 1 Gradient elution table
[0058]
[0059] Mass spectrometry conditions: ion source ESI (electrospray ionization) source; detection method positive ion detection. The process collects data in IDA (information-dependent basis) mode. In this mode, the acquisition software (Analyst TF 1.8.1 version, AB Sciex) performs primary and secondary mass spectrometry data acquisition based on the IDA function under the control of the control software (Analyst TF 1.8.1 version, ABSciex). In each data acquisition cycle, molecular ions with the highest signal intensity and a mass-to-charge ratio (m / z) greater than 100 are selected for secondary mass spectrometry acquisition. The fragmentation of these ions uses a bombardment energy of 35±15eV, 10 secondary spectra, and an accumulation time of 50ms for each product ion. The ESI ion source parameter settings are shown in Table 2:
[0060] Table 2 ESI ion source related parameter settings
[0061]
[0062] In the in vitro experiments, a total of 13 AGEs were detected, such as Figure 1As shown, including Pentosidine, Argpyrimidine, Furosine, Nε-carboxymethyl-lysine, Nε-carboxyethyl lysine, Vesperlysine A, Vesperlysine B, Vesperlysine C, Methylglyoxal-lysine dimer, Glyoxal-lysine dimer, Glyoxal-hydroimidazolone isomers, Methylglyoxal-derived hydroimidazolones, Glyoxal lysine amide, etc. From Figure 2 It can be seen that except for pentosidine and Nε-carboxyethyl lysine, the contents of all other AGEs in the model group were higher than those in the blank group, and the contents of AGEs in the drug-treated groups decreased, indicating that the seven Chinese medicines all have the effect of inhibiting the formation of AGEs. Figure 3 The results showed that the drug with the best inhibitory effect on arginine pyrimidine was Scutellaria baicalensis, the drug with the best inhibitory effect on dihydrofuran pyrimidine was Scutellaria baicalensis, the drug with the best inhibitory effect on Nε-carboxymethyl lysine was cinnamon bark, the drug with the best inhibitory effect on Nε-carboxyethyl lysine was Paeonia suffruticosa moutan bark, the drug with the best inhibitory effect on pyrimidine protein lysine A was Scutellaria baicalensis, the best drug with the best inhibitory effect on pyrimidine protein lysine B was Rhei officinalis, the best drug with the best inhibitory effect on pyrimidine protein lysine C was Rhei officinalis, the best drug with the best inhibitory effect on methylglyoxal-lysine dimer was Scutellaria baicalensis, the best drug with the best inhibitory effect on glyoxal-lysine dimer was Scutellaria baicalensis, the best drug with the best inhibitory effect on glyoxal-hydroimidazolone isomers was cinnamon bark, the best drug with the best inhibitory effect on methylglyoxal-derived hydroimidazolone was Scutellaria baicalensis, and the best drug with the best inhibitory effect on glyoxal lysine amide was Paeonia suffruticosa moutan bark. Among all AGEs, pyrimidine protein lysine A accounts for the highest proportion, while methylglyoxal-lysine dimer and glyoxal lysine amide account for the lowest proportion. Taking into account the proportion of each AGE in the total AGEs and the different inhibitory effects of each drug on a single AGE, it is concluded that Scutellaria baicalensis has the strongest inhibitory effect on the formation of total AGEs among these seven drugs.
[0063] Example 2
[0064] Cell experiments
[0065] 1. Establishment of the Cellular High Glucose Model
[0066] HBZY-1 (rat glomerular mesangial cells) cells were starved for 12 h in a medium without fetal bovine serum. Two different cell culture media, low-glucose and high-glucose, were prepared. The low-glucose medium had a glucose concentration of 5.6 mM, contained 5% heat-extinguished fetal bovine serum and 1% penicillin-streptomycin; the high-glucose medium had a glucose concentration of 30 mM, contained 5% heat-extinguished fetal bovine serum and 1% penicillin-streptomycin.
[0067] Blank group: The starved cells were cultured with DMEM low-glucose medium for 48 h.
[0068] Model group: Starved cells were cultured with DMEM high-glucose medium for 48 h.
[0069] Drug administration group: The Chinese herbal extract was dissolved in DMSO, filtered and sterilized with a sterile filter, and added to DMEM high-glucose medium to make the drug concentration 100 g / ml, and then inoculated into the starved cells and cultured for 48 hours.
[0070] 2. Detection of AGEs in cells by liquid chromatography-mass spectrometry
[0071] A total of 1000 L of methanol was added to each well on the cell culture plate. The cells were mechanically separated from the plate with a scraper and transferred to a glass vial. The samples were completely dried using a vacuum dryer. A total of 1 mL of HCl was added to each sample. The samples were incubated in a nitrogen blown heating block at 110°C for 20 hours, then dried under nitrogen blows, and the bottom solids were dissolved in 500 L of solution (water: acetonitrile = 1:1, 0.1% formic acid) and tested for liquid quality. The liquid quality conditions were the same as in Example 1.
[0072] In the cell experiment, a total of 11 types of AGEs were detected, such as Figure 4As shown, including pentosidine, arginine pyrimidine, furosine, Nε-carboxymethyl-lysine, Nε-carboxyethyl lysine, vesperlysine A, vesperlysine B, vesperlysine C, glyoxal-lysine dimer, glyoxal-hydroimidazolone isomers, methylglyoxal-derived hydroimidazolones, etc. Figure 5 and Figure 6 The results showed that the drug with the best inhibitory effect on arginine pyrimidine was Scutellaria baicalensis, the drug with the best inhibitory effect on dihydrofuran pyrimidine was Scutellaria baicalensis, the drug with the best inhibitory effect on Nε-carboxymethyl lysine was Paeonia lactiflora, the drug with the best inhibitory effect on Nε-carboxyethyl lysine was Scutellaria baicalensis, the drug with the best inhibitory effect on pyrimidine protein lysine A was Scutellaria baicalensis, the best drug with the best inhibitory effect on pyrimidine protein lysine B was Cinnamon bark, the best drug with the best inhibitory effect on pyrimidine protein lysine C was Paeonia suffruticosa moutan, the drug with the best inhibitory effect on glyoxal-lysine dimer was Fructus Aurantii Immaturus, the best drug with the best inhibitory effect on glyoxal-hydroimidazolone isomers was Scutellaria baicalensis, and the best drug with the best inhibitory effect on methylglyoxal-derived hydroimidazolone was Scutellaria baicalensis. Among all AGEs, pyrimidine protein lysine A accounts for the highest proportion, and methylglyoxal-derived hydroimidazole accounts for the lowest proportion. Taking into account the proportion of each AGE in the total AGEs and the different inhibitory effects of each drug on a single AGE, it is concluded that Scutellaria baicalensis has the strongest inhibitory effect on the formation of total AGEs among these seven drugs.
[0073] Example 3
[0074] Animal experiment verification
[0075] 1. Establishment of animal diabetes model
[0076] Mice were fed a high-sugar, high-fat diet for one month and then switched to a clean-grade standard maintenance mouse diet. Subsequently, STZ dissolved in citrate buffer (pH 4.2) was injected into the left lower cavity of mice at a dose of 30 mg / kg body weight once a day for 2-4 consecutive days. If the fasting blood glucose level of the mice did not exceed 7.0 mmol / L, an additional injection was given. The mice were fasted for 8 hours before each injection. The control group (C) was only given a clean-grade standard maintenance diet and injected with the same dose of citrate buffer. All other conditions were kept the same between the two groups. One week after STZ injection, mice with fasting blood glucose (FBG) levels higher than or equal to 16.7 mmol / L were considered to have successfully established a diabetic model. Mice in each group had free access to food and water every day, among which the positive drug group (P) was gavaged with aminoguanidine solution at a dose of 0.1 g / kg body weight every day, the low-dose administration group (L) was gavaged with drugs at a dose of 0.2 g / kg body weight every day, and the high-dose administration group (H) was gavaged with drugs at a dose of 0.8 g / kg body weight every day.
[0077] 2. Detection of AGEs in animals by liquid chromatography-mass spectrometry
[0078] The mice were fasted but provided with water for 8 hours before dissection. The mice were killed by dislocation of the neck, and the kidneys were removed, washed with 0.9% saline, and placed in a -80℃ refrigerator for later use. Under liquid nitrogen, the organs were ground into powder in a mortar, and 10 mg of each was taken into a grinding tube, added to 200μL 10% TCA, and homogenized for 180s at 70Hz using an automatic homogenizer after adding grinding beads, and incubated on ice for 30 minutes to precipitate the protein. Centrifuged at 12000g, 4℃ for 10 minutes, and the precipitate was dissolved in 500L of sodium borate buffer (200mM, pH=9.2) with sodium borohydride (100mM). Incubated at room temperature for 2 hours, then TFA (trifluoroacetic acid) (200g / L) was added, and the protein was precipitated by centrifugation at 12000g for 10 minutes. An equal amount of TFA was added again and centrifuged, and the supernatant was removed. After all TFA was removed, HCl was added. Heat the mixture to 110°C in a nitrogen blower heating block for 20 hours. Blow the liquid dry under nitrogen blow, and dissolve the solid matter in the LC-MS / MS starting eluent to start LC-MS / MS testing. The LC-MS conditions are the same as in Example 1.
[0079] In animal experiments, a total of 9 types of AGEs were detected, such as Figure 7As shown, including arginine pyrimidine (Argpyrimidine), dihydrofuran pyrimidine (Furosine), Nε-carboxymethyl lysine (Nε-carboxymethyl lysine), Nε-carboxyethyl lysine (Nε-carboxyethyl lysine), pyrimidine protein lysine A (Vesperlysine A), pyrimidine protein lysine B (Vesperlysine B), glyoxal-hydroimidazolone isomers (Glyoxal-hydroimidazolone isomers), methylglyoxal-derived hydroimidazolones (Methylglyoxal-derived hydroimidazolones) and Nω-carboxymethyl arginine (Nω-carboxymethyl arginine) and the like. Figure 8 The results showed that Scutellaria baicalensis had an excellent inhibitory effect on AGEs in animals, and showed dose differences. Among all AGEs, the inhibitory effect of high-dose Scutellaria baicalensis was significantly better than that of low-dose Scutellaria baicalensis. For arginine pyrimidine, the inhibitory effect of positive drugs was weaker than that of Scutellaria baicalensis. For dihydrofuran pyrimidine, the inhibitory effect of positive drugs was between high-dose and low-dose Scutellaria baicalensis. For Nε-carboxymethyl lysine, the inhibitory effect of positive drugs was between high-dose and low-dose Scutellaria baicalensis. For Nε-carboxyethyl lysine, the inhibitory effect of positive drugs was between high-dose and low-dose Scutellaria baicalensis. The inhibitory effect of positive drugs was weaker than that of Scutellaria baicalensis; for pyrimidine protein lysine A, the inhibitory effect of positive drugs was higher than that of Scutellaria baicalensis; for pyrimidine protein lysine B, the inhibitory effect of positive drugs was between high and low doses of Scutellaria baicalensis; for glyoxal-hydroimidazolone isomers, the inhibitory effect of positive drugs was between high and low doses of Scutellaria baicalensis; for methylglyoxal-derived hydroimidazolone, the inhibitory effect of positive drugs was between high and low doses of Scutellaria baicalensis; for Nω-carboxymethylarginine, the inhibitory effect of positive drugs was between high and low doses of Scutellaria baicalensis.
[0080] In summary, the present invention first synthesizes AGEs in vitro to determine whether the selected drug has the ability to inhibit AGEs, uses a high-sugar model cell experiment to screen out the drug with the highest inhibitory ability, and uses a diabetes model animal experiment to determine the effectiveness and dosage differences of the screened drugs in vivo, thereby quickly screening the desired drugs. This method is simple and efficient.
Claims
1. A method for screening drugs for inhibiting the activity of advanced glycation end products based on UPLC-MS, characterized in that: The following steps are involved: (1) Extraction of drugs: The screened Chinese medicine was crushed into powder, and then boiled in 95% ethanol solution for 2 hours to extract the Chinese medicine components, and finally evaporated and concentrated at 60°C until it was in a paste state to obtain the Chinese medicine extract; (2) Synthesis of AGEs in vitro: A model group, a blank group, and a drug-treated group were set up, and the treatment of each group was as follows: Model group: 5 mg / mL bovine serum albumin and 0.5 mol / L D-ribose were mixed in PBS at pH 7.4, left at room temperature for one day to fully dissolve, filtered with a 0.22 μm sterile filter, and the mixture was incubated at 37°C in 5% CO2-95% O2 for 14 days; Blank group: 5 mg / mL bovine serum albumin was used, sterilized by filtration with a 0.22 μm sterile filter, and incubated at 37°C in 5% CO2-95% O2 for 14 days; Administration group: 5 mg / mL bovine serum albumin and 0.5 mol / L D-ribose were mixed in PBS at pH 7.4, left at room temperature for one day to fully dissolve, filtered and sterilized with a 0.22 μm sterile filter, the Chinese herbal extract was dissolved with 10% dimethyl sulfoxide, filtered and sterilized, and then added to the mixed reaction system of BSA and D-ribose at an amount of 2 mg / ml, and the mixture was incubated at 37°C in 5% CO2-95% O2 for 14 days; (3) Liquid quality detection of AGEs: After incubation, each group of samples was dialyzed with PBS to remove unreacted sugars, and then the samples were freeze-dried and dissolved in water, and sodium borohydride sodium borate buffer was added, incubated at room temperature for 2 hours, and then trifluoroacetic acid solution was added, and the protein was precipitated by centrifugation at 12000g for 10 minutes. An equal amount of trifluoroacetic acid solution was added again and centrifuged, and the supernatant was removed. After all TFA was removed, HCl was added, and then the mixture was heated to 110°C under nitrogen blowing for 20 hours. The liquid was blown dry under nitrogen blowing, and the solid matter was dissolved in the LC-MS / MS starting eluent for liquid mass spectrometry testing. In the mobile phase, solvent A: 0.1% formic acid, solvent B: acetonitrile, flow rate 0.3mL / min, column temperature 40°C, gradient elution program as follows; , Mass spectrometry conditions: ion source ESI source, detection mode is positive ion detection, parameters are as follows: , The content of synthesized AGEs in each group was analyzed; (4) Establishment of cell high glucose model: HBZY-1 cells were starved for 12 h in a culture medium without fetal bovine serum, and a model group, a blank group, and a drug-treated group were set up. The treatment of each group was as follows: Blank group: HBZY-1 cells after starvation were cultured in DMEM low-glucose medium for 48 h; Model group: HBZY-1 cells after starvation were cultured in DMEM high-glucose medium for 48 h; Drug administration group: The Chinese herbal extract was dissolved in DMSO, filtered and sterilized with a sterile filter, added to DMEM high-glucose medium to a drug concentration of 100 g / ml, and then inoculated into starved HBZY-1 cells for 48 h. (5) Detection of AGEs in cells by liquid chromatography-mass spectrometry Methanol was added to each group, and the cells were mechanically separated from the plate with a scraper and transferred to a glass vial, completely dried, HCl was added to each sample, and the sample was incubated in a nitrogen blowing heating block at 110°C for 20 hours, and then dried under nitrogen blowing, and the bottom solid was dissolved in a mixed solution of acetonitrile and water containing 0.1% formic acid, with a volume ratio of water: acetonitrile of 1:1, and liquid chromatography-mass spectrometry was performed. The liquid chromatography-mass spectrometry conditions were the same as those in step (3), and the content of synthesized AGEs in each group was analyzed; (6) Based on the contents of AGEs synthesized in steps (3) and (5), a comprehensive analysis is performed to screen out the drug with the relatively lowest content of synthesized AGEs.
2. The screening method according to claim 1, characterized in that In step (3), in the sodium borohydride sodium borate buffer, the concentration of sodium borohydride is 100 mM, the concentration of the sodium borate buffer is 200 mM, and the pH is 9.
2.
3. The screening method according to claim 1, characterized in that In step (3), the concentration of the trifluoroacetic acid solution is 200 g / L.
4. The screening method according to claim 1, characterized in that In step (3), data was collected in IDA mode. In each data collection cycle, the molecular ions with the highest signal intensity and mass-to-charge ratio greater than 100 were selected for secondary mass spectrometry collection. The bombardment energy used for ion fragmentation was 35±15 eV, and the accumulation time for each product ion was 50 ms.
5. The screening method according to claim 1, characterized in that In step (4), the glucose concentration of the low-glucose medium is 5.6 mM, containing 5% heat-extinguished fetal bovine serum and 1% penicillin-streptomycin; the glucose concentration of the high-glucose medium is 30 mM, containing 5% heat-extinguished fetal bovine serum and 1% penicillin-streptomycin.
